Skip to content
Friday, February 3, 2023
HealthCare Middle East & Africa Magazine

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
    • GOVERNMENT
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • COMPANY PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Siemens Healthineers snaps multi-year pact with Unilabs worth over US$219M
  • <strong>India’s Ministry of Finance sets aside US$10B for the health sector in the 2023/24 budget</strong>
  • Ministry of Health concerned with rising malaria cases in the past year
  • eHealth Africa upgrades its application to improve public health outcomes
  • NHA appoints Praveen Sharma as Director, RS Sharma tenure ends as CEO
  • Action needed on trafficked medical products - United Nations Office on Drugs and Crime
  • African leaders commit to end AIDS among children by 2030
  • <strong>President of Ghana launches 300-bed capacity block at 37 Military Hospital</strong>
  • Apollo Indraprastha Hospitals co-hosts meeting with MediSage on cancer management
  • <strong>MoHAP, DoH and DHA announce</strong> <strong>seamless health data integration in the UAE</strong>
You are here
  • Home
  • Novartis

Tag: Novartis

Novartis’ Sandoz and Ibnsina Pharma ink deal to promote the safe use of OTC medications

30 January 202330 January 2023

EGYPT – Sandoz Egypt Pharma, a division of the Novartis Group, and Ibnsina Pharma have signed a distribution and promotion agreement for the Sandoz over-the-counter (OTC) portfolio of products. Sandoz…

Read More

Novartis divests five eye treatments for up to US$175 million

15 December 202216 December 2022

USA — Swiss pharma giant Novartis has sold five of its ophthalmic drugs to eye therapy company Harrow for a one-time payment of US$130 million, plus additional milestone payments of…

Read More

Novartis’ antimalarial candidate to move forward to phase 3 development next year

29 November 202229 November 2022

SWITZERLAND —Novartis and Medicines for Malaria Venture (MMV) have announced the decision to advance novel drug combination ganaplacide/lumefantrine into phase 3 development for the treatment of patients with acute uncomplicated…

Read More

Novartis signs landmark licensing deal with MPP for high-priced cancer drug

21 October 202221 October 2022

SWITZERLAND — Pharmaceutical giant Novartis has signed a licensing agreement increasing access to vital leukemia treatment, the Medicines Patent Pool (MPP) has said, marking the first-ever such agreement for a…

Read More

Swiss pharma giant Novartis to lay off 400 workers from Dublin site

14 October 202214 October 2022

IRELAND – Swiss pharmaceutical company, Novartis has announced plans to cut up to 400 jobs from its Dublin operations. The job cuts will occur over the next two years at…

Read More

Novartis Corporation partners with IJN to combat cardiovascular disease in Malaysia

5 August 20225 August 2022

MALAYSIA – Novartis Corporation (Malaysia) Sdn Bhd (NCSB) and Institut Jantung Negara (IJN) have formed the first ever scientific partnership to help Malaysians in improved cardiac care. The cooperation is…

Read More

Novartis, Egypt’s Cleopatra Hospitals Group ink pact for cardiovascular disease treatment

29 July 202229 July 2022

EGYPT – Pharma giant Novartis Pharma Egypt and Cleopatra Hospitals Group (CHG), Egypt’s best provider of medical and healthcare services, have entered into a strategic partnership deal to provide the…

Read More

FDA accepts Sandoz’s application for MS biosimilar, challenging Biogen’s Tysabri

26 July 202226 July 2022

SWITZERLAND – Sandoz’s biologics license application (BLA) has been accepted by the US Food and Drug Administration (FDA) for a proposed ‘first-of-a-kind’ biosimilar natalizumab, developed by Polpharma Biologics, for the…

Read More

Kenya partners Fred Hollows Foundation, Novartis to unveil eye health programme

19 July 202219 July 2022

KENYA – Pharma giant Novartis Pharmaceutical, non-profit aid organization The Fred Hollows Foundation and Kenya have inked a strategic investment deal to inaugurate the ‘Integrated Eye Health Program’ for blindness…

Read More

Novartis-led UK alliance to invest, implement digital cardio innovations

6 July 20226 July 2022

UNITED KINGDOM – Novartis has launched the Novartis Biome UK Heart Health Catalyst, an initiative seeking healthtech start-ups developing digital tools to enhance the prevention and management of cardiovascular disease…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

Africa Health Expo 300x600 Sidebar

LATEST NEWS

  • Siemens Healthineers snaps multi-year pact with Unilabs worth over US$219M
  • India’s Ministry of Finance sets aside US$10B for the health sector in the 2023/24 budget
  • Ministry of Health concerned with rising malaria cases in the past year
  • eHealth Africa upgrades its application to improve public health outcomes
  • NHA appoints Praveen Sharma as Director, RS Sharma tenure ends as CEO

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Rwanda Sanofi Science & Technology South Africa Switzerland Tanzania Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

HealthCare Middle East & Africa Follow

Africa's No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa & the World

HealthCareAfro
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 2, 2023

#HCMEAMagazine #Issue4
As we mark World Cancer Day this Saturday, 4th February, we highlight the cancer burden and strategies being explored by experts, particularly in Africa, to contain the disease in this article.

Have a read on the link below;

https://t.co/MOvJjCYz30

Reply on Twitter 1621057821566709760 Retweet on Twitter 1621057821566709760 Like on Twitter 1621057821566709760 1 Twitter 1621057821566709760
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 2, 2023

#NationalCancerSummit2023
The HealthCare Middle East & Africa Magazine team is present at the National Cancer Summit @NCIKenya that is happening at Safari Park Hotel, Nairobi.

Visit our booth to get more insights about our magazine.

https://t.co/G8kVljPfqY

4

Reply on Twitter 1621049414629625857 Retweet on Twitter 1621049414629625857 1 Like on Twitter 1621049414629625857 Twitter 1621049414629625857
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 2, 2023

Innovate Life Sciences Lab has launched its new genomics testing laboratory based at @DxbSciencePark that will use #ArtificialIntelligence to advance precision medicine

https://t.co/XaOEUInRXz

#LifeSciences #Genomics #testing #UAE #Dubai #healthcare #lab #clinicalresearch

Reply on Twitter 1621033276528893952 Retweet on Twitter 1621033276528893952 Like on Twitter 1621033276528893952 Twitter 1621033276528893952
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 2, 2023

UK supports Malawi with US$0.59m for cholera emergency response

https://t.co/b2jaLhxAl3

#digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Covid19 #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory #medical

Reply on Twitter 1621027573915422721 Retweet on Twitter 1621027573915422721 2 Like on Twitter 1621027573915422721 1 Twitter 1621027573915422721
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 2, 2023

Ghana successfully eliminates Human African Trypanosomiasis

https://t.co/UWijC0yg8E

#digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Covid19 #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory #medical

Reply on Twitter 1621027388397350913 Retweet on Twitter 1621027388397350913 1 Like on Twitter 1621027388397350913 Twitter 1621027388397350913
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa

Food Business Africa

Food Safety Africa

Milling & Baking Africa

Sustainable Packaging Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.